Aisling Capital Management »

Viracta Therapeutics shares owned by Aisling Capital Management

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Aisling Capital Management from 13F filings

Historical chart of Aisling Capital Management investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Aisling Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $157k 289k 0.54
2024-03-31 $294k 289k 1.02
2023-12-31 $165k 289k 0.57
2023-09-30 $300k 289k 1.04
2023-06-30 $407k 289k 1.41
2023-03-31 $459k 289k 1.59
2022-12-31 $421k 289k 1.46
2022-09-30 $1.2M 289k 4.27
2022-06-30 $1.1M 289k 3.88
2022-03-31 $1.4M 289k 4.76
2021-12-31 $1.1M 289k 3.65
2021-09-30 $2.3M 289k 8.02
2021-06-30 $3.3M 289k 11.34